Thomas M. Habermann

Research interests

Publications

• Post-Transplantation Lymphoproliferative Disorders in Adults

  New England Journal of Medicine · 2018 · 10.1056/nejmra1702693

• Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

  Nature Medicine · 2018 · https://doi.org/10.1038/s41591-018-0016-8

• Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

  Blood · 2017 · 10.1182/blood-2017-02-765685

• Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma

  Nature Medicine · 2015 · https://doi.org/10.1038/nm.3884

• Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy

  Journal of Clinical Oncology · 2014 · 10.1200/jco.2013.51.5866

• Etiologic Heterogeneity Among Non-Hodgkin Lymphoma Subtypes: The InterLymph Non-Hodgkin Lymphoma Subtypes Project

  JNCI Monographs · 2014 · 10.1093/jncimonographs/lgu013

• Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study

  Journal of Clinical Oncology · 2014 · 10.1200/jco.2014.55.5714

• ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

  Blood · 2014 · 10.1182/blood-2014-04-571091

• Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource

  Journal of Clinical Oncology · 2013 · 10.1200/jco.2012.48.3990

• Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)

  Journal of Clinical Oncology · 2012 · 10.1200/jco.2012.43.4803

• Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

  Proceedings of the National Academy of Sciences · 2012 · https://doi.org/10.1073/pnas.1121343109

• A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

  Leukemia · 2010 · 10.1038/leu.2010.226

• Phase I Study of Ipilimumab, an Anti–CTLA-4 Monoclonal Antibody, in Patients with Relapsed and Refractory B-Cell Non–Hodgkin Lymphoma

  Clinical Cancer Research · 2009 · 10.1158/1078-0432.ccr-09-1339

• Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

  Blood · 2009 · 10.1182/blood-2008-10-186999

• Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

  Journal of Clinical Oncology · 2008 · 10.1200/jco.2007.15.3429

• SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma

  Blood · 2007 · 10.1182/blood-2007-07-100115

• Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma

  Journal of Clinical Oncology · 2006 · https://doi.org/10.1200/jco.2005.05.1003

• Association of Perceived Medical Errors With Resident Distress and Empathy

  JAMA · 2006 · https://doi.org/10.1001/jama.296.9.1071

• Bleomycin Pulmonary Toxicity Has a Negative Impact on the Outcome of Patients With Hodgkin's Lymphoma

  Journal of Clinical Oncology · 2005 · 10.1200/jco.2005.02.7243

• Relationship between increased personal well-being and enhanced empathy among

  Journal of General Internal Medicine · 2005 · 10.1007/s11606-005-0102-8

• Relationship between increased personal well-being and enhanced empathy among internal medicine residents.

  PubMed · 2005 · 10.1111/j.1525-1497.2005.0108.x

• Chemotherapy With or Without Radiotherapy in Limited-Stage Diffuse Aggressive Non-Hodgkin's Lymphoma: Eastern Cooperative Oncology Group Study 1484

  Journal of Clinical Oncology · 2004 · 10.1200/jco.2004.06.088

• The well-being of physicians

  The American Journal of Medicine · 2003 · 10.1016/s0002-9343(03)00117-7

• EPSTEIN-BARR VIRUS-INDUCED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS

  Transplantation · 1999 · 10.1097/00007890-199911270-00015

• Pretransplantation Assessment of the Risk of Lymphoproliferative Disorder

  Clinical Infectious Diseases · 1995 · 10.1093/clinids/20.5.1346

Current projects

No projects listed.